Posted on May 22, 2023
Our journal adheres to Principles of Transparency and Best Practice in Scholarly Publishing (ver. 4, published September 15, 2022; https://doaj.org/apply/transparency) developed by Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishing Association (OASPA), and the World Association of Medical Editors (WAME). Compliance checklist of the journal to the joint statement is as follows.
JCS adheres to the Guideline on Good Publication of COPE (https://publicationethics.org), Recommendations of International Committee of Medical Journal Editors (http://www.icmje.org/recommendations), and Good Publication Practice Guidelines for Medical Journals of Korean Association of Medical Journal Editors (http://kamje.or.kr). Our publication ethics are displayed on the Editorial Policies (Research & Publication Ethics) tab of the journal homepage.
In case the journal faces suspected cases of research and publication misconduct, such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, an undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and so on, the resolution process will follow the flowchart provided by COPE (https://publicationethics.org/resources/flowcharts). JCS will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when needed.
JCS has an online submission and peer review system at https://www.jchestsurg.org/submission. All papers, including those invited by the editor, are subject to a rigorous peer review process. JCS has adopted a double-blind peer review policy, in which the identities of both the authors and reviewers are kept anonymous to each other throughout the review process. However, the editor managing the review process will have visibility of the authors and reviewers’ identities. The Editorial Board selects reviewers based on expertise, publication history, and past reviews. During the peer review process, reviewers can interact directly or exchange information (e.g., via submission systems or email) with only an editor, which is known as “independent review.” An initial decision will normally be made within 4‒6 weeks of receipt of a manuscript. No information about the review process or editorial decision process is published on the article page.
All manuscripts from editors, employees, or members of the Editorial Board are processed the same way as other unsolicited manuscripts. During the review process, they will not engage in the selection of reviewers nor the decision process. Editors will not handle their own manuscripts even if they are commissioned ones.
All articles in JCS include the dates of submission, revision, acceptance, and publication on their article page.
JCS is freely accessible from the journal website (http://www.jchestsurg.org/) according to the Creative Commons License (https://creativecommons.org/licenses/by-nc/4.0/). A free full-text service both in the XML and PDF formats is available immediately upon publication without embargo period.
Journal propagation has been done through the journal website and distribution of an introduction pamphlet. Invitations to submit a manuscript are usually targeted towards presenters at conferences, seminars, or workshops related to the journal's aims and scope.
In addition, we declare that these principles acknowledge the responsibility of publishers and editors in promoting accessibility, diversity, equity, and inclusivity in all aspects of publication. Editorial decisions are based solely on scholarly merit, and should not be influenced by the authors' nationality, ethnicity, political beliefs, race, or religion. JCS is committed to ensuring that its policies do not create an exclusionary environment and will regularly evaluate them for inclusiveness.
In Seok Jeong, M.D. , Woong-Han Kim, M.D. , Jong Hyun Baek, M.D. , Chang-Hyu Choi, M.D. , Chang Woo Choi, M.D. , Euy Suk Chung, M.D. , Jae Seok Jang, M.D. , Woo Sung Jang, M.D. , Hanna Jung, M.D. , Jae-Seung Jung, M.D. , Pil Je Kang, M.D. , Dong Jung Kim, M.D. , Do Wan Kim, M.D. , Hyoung Soo Kim, M.D. , Jae Bum Kim, M.D. , Woo-Shik Kim, M.D. , Young Sam Kim, M.D. , Jae Gun Kwak, M.D. , Haeyoung Lee, M.D. , Seok In Lee, M.D. , Jae Woong Lim, M.D. , Se Jin Oh, M.D. , Tak-Hyuck Oh, M.D. , Chun Soo Park, M.D. , Kyoung Min Ryu, M.D. , Man-Shik Shim, M.D. , Joohyung Son, M.D. , Kuk Hui Son, M.D. , Seunghwan Song, M.D. , on behalf of The Korean Society for Thoracic and Cardiovascular Surgery COVID- ECMO Task Force Team
J Chest Surg 2021; 54(1): 2-8
Samina Park, M.D. , Yongwoo Chung, M.D. , Hyun Joo Lee, M.D. , In Kyu Park, M.D. , Chang Hyun Kang, M.D. , Young Tae Kim, M.D.
Korean J Thorac Cardiovasc Surg 2020; 53(3): 114-120
Sung-Jin Hong, M.D. , Jung-Sun Kim, M.D., Ph.D. , Geu-Ru Hong, M.D.
J Chest Surg 2021; 54(3): 165-171
Young Kern Kwon, M.D. , Sung Jun Park, M.D. , Suk Jung Choo, M.D., Ph.D. , Tae Jin Yun, M.D., Ph.D. , Jae Won Lee, M.D., Ph.D. , Joon Bum Kim, M.D., Ph.D.
Korean J Thorac Cardiovasc Surg 2020; 53(6): 346-352
Sang Pil Kim, M.D. , Juhyun Lee, M.D. , Sung Kwang Lee, M.D. , Do Hyung Kim, M.D.
J Chest Surg 2021; 54(3): 206-213
Hoyong Jun, M.D. , Saebeom Hur, M.D.
Korean J Thorac Cardiovasc Surg 2020; 53(4): 200-204